Pharmafile Logo
Pharmafocus logo
Advanced Search

Cell BioEngines announces exclusive licencing agreement for cancer cure

January 26, 2023
Medical Communications

US-based cell and gene therapy company Cell BioEngines has announced its exclusive licencing agreement with Icahn School of Medicine at …

News

t.bio chooses Automata as partner for automating a key aspect of its production of iPSC derived human cells

January 26, 2023
Business Services

26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it …

News
Press release

Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease

January 26, 2023
Business Services

26 January 2023 Galway, Ireland – Orbsen Therapeutics Limited (“Orbsen”), a global leader in stromal cell immunotherapies, today announces encouraging …

News
Press release

First CAR T-cell therapy recommended for routine use on the NHS in England

January 26, 2023
Business Services

26th JANUARY 2023, LONDON, UK – Gilead Sciences Ltd. and Kite, a Gilead company, today announced that the National Institute …

News
Press release

Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases

January 26, 2023
Business Services

Paris, France and Eastleigh, UK – 26 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in …

News
Press release

Brits Living with Diabetes Feel Stigma and Bias Impact Their Ability to Manage Their Condition

January 26, 2023
Business Services

MAIDENHEAD, BERKSHIRE – TUESDAY 24 JANUARY 2023 – With diabetes prevalence expected to reach almost 5.5 million across the UK …

News
Press release

US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections

January 25, 2023
Business Services

Brighton, United Kingdom – 25 January 2023 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on …

News
Press release

Vertex and CRISPR Therapeutics Announce EMA Marketing Authorization Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa

January 25, 2023
Business Services

LONDON, UK and ZUG, Switzerland, January 25, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that …

News
Press release

STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference

January 25, 2023
Business Services

25 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …

News
Press release

Scancell Holdings plc: Interim Results for the 6 months ended 31 October 2022

January 25, 2023
Business Services

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces …

News
Press release

Sosei Heptares Webinar Presentation for FY2022 Financial Results

January 25, 2023
Business Services

Tokyo, Japan and Cambridge, UK, 25 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …

News
Press release

Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug

January 25, 2023
Medical Communications

Bristol Myers Squibb (BMS) has filed a lawsuit against AstraZeneca, alleging that AstraZeneca’s Imjudo infringes patents from its blockbuster drug …

News

Eli Lilly plans to invest $450m at production site in Research Triangle Park

January 25, 2023
Manufacturing and Production

US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle …

News

Poxel given EC’s Orphan Drug Designation for rare metabolic disorders

January 25, 2023
Research and Development

Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …

News

Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1

January 25, 2023
Medical Communications

US-based Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems Taqpath Seq HIV-1 Genotyping kit. It …

News

finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation

January 24, 2023
Business Services

London, 24th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the …

News
Press release

UK seeing exodus of R&D activity, research reveals

January 24, 2023
Business Services

London, 24 January 2023: The UK is experiencing a crisis where firms are moving R&D activity abroad, according to research …

News
Press release

Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence

January 24, 2023
Business Services

London, UK and Antwerp, Belgium. 24th January 2023 – Amber Therapeutics (‘Amber’ or the ‘Company’), a University of Oxford spinout …

News
Press release

2022 Novo Holdings Seed Investments team Review/Business Update

January 24, 2023
Business Services

Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo Holdings, today …

News
Press release

Global Company Foot Science International Choose Onyx Health

January 24, 2023
Business Services

Leading orthotics company Foot Science International has joined forces with creative agency Onyx Health to launch a new medical education …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025